Earnings Feed
Start Free
Home/Filings/4/0001104659-10-021344
4//SEC Filing

BOYLE J DAVID II 4

Accession 0001104659-10-021344

CIK 0000873303other
View on SEC.govCompany Profile

Filed

Apr 21, 8:00 PM ET

Accepted

Apr 22, 9:34 PM ET

Size

16.9 KB

Accession

0001104659-10-021344

Insider Transaction Report

Form 4
Period: 2010-04-20
AVI BIOPHARMA INCAVII
BOYLE J DAVID II
CFO
Transactions
  • Award

    Non-Qualified Stock Option (right to buy)

    2010-04-20+50,000→ 50,000 total
    Exercise: $1.24From: 2010-04-20Exp: 2020-04-20→ Common Stock (50,000 underlying)
Holdings

  • Incentive Stock Option (right to buy)

    Exercise: $1.21From: 2008-08-18Exp: 2018-08-18→ Common Stock (247,932 underlying)
    247,932

  • Incentive Stock Option (right to buy)

    Exercise: $1.45From: 2011-02-09Exp: 2020-02-09→ Common Stock (97,241 underlying)
    97,241

  • Non-Qualified Stock Option (right to buy)

    Exercise: $1.45From: 2011-02-09Exp: 2020-02-09→ Common Stock (82,759 underlying)
    82,759

  • Incentive Stock Option (right to buy)

    Exercise: $0.92From: 2010-02-10Exp: 2019-02-10→ Common Stock (50,000 underlying)
    50,000

  • Common Stock

    65,282

  • Incentive Stock Option (right to buy)

    Exercise: $1.30From: 2011-03-09Exp: 2020-03-09→ Common Stock (10,000 underlying)
    10,000

  • Non-Qualified Stock Option (right to buy)

    Exercise: $1.30From: 2011-03-09Exp: 2020-03-09→ Common Stock (90,000 underlying)
    90,000

  • Non-Qualified Stock Option (right to buy)

    Exercise: $0.92From: 2010-02-10Exp: 2019-02-10→ Common Stock (100,000 underlying)
    100,000

  • Non-Qualified Stock Option (right to buy)

    Exercise: $1.21From: 2008-08-18Exp: 2018-08-18→ Common Stock (102,068 underlying)
    102,068
Footnotes (4)
  • [F1]The Stock Option Grant vest as follows: 1/3 vest one year from date of grant and 1/3 each year thereafter until all shares vest three years from grant date.
  • [F2]The options vest in equal annual installments over three years beginning on August 18, 2008.
  • [F3]Grant vest 100% on grant date.
  • [F4]Price not required on initial report of stock option granted.

Documents

1 file

Issuer

AVI BIOPHARMA INC

CIK 0000873303

→
Entity typeother

Related Parties

1
  • filerCIK 0001331152

Filing Metadata

Form type
4
Filed
Apr 21, 8:00 PM ET
Accepted
Apr 22, 9:34 PM ET
Size
16.9 KB
View on SEC.gov